Abstract

A more thorough understanding of the differences in DNA methylation (DNAm) profiles in populations may hold promise for identifying molecular mechanisms through which genetic and environmental factors jointly contribute to human diseases. Inflammation is a key molecular mechanism underlying several chronic diseases including cardiovascular disease, and it affects DNAm profile on both global and locus-specific levels. To understand the impact of inflammation on the DNAm of the human genome, we investigated DNAm profiles of peripheral blood leukocytes from 966 African American participants in the Genetic Epidemiology Network of Arteriopathy (GENOA) study. By testing the association of DNAm sites on CpG islands of over 14,000 genes with C-reactive protein (CRP), an inflammatory biomarker of cardiovascular disease, we identified 257 DNAm sites in 240 genes significantly associated with serum levels of CRP adjusted for age, sex, body mass index and smoking status, and corrected for multiple testing. Of the significantly associated DNAm sites, 80.5% were hypomethylated with higher CRP levels. The most significant Gene Ontology terms enriched in the genes associated with the CRP levels were immune system process, immune response, defense response, response to stimulus, and response to stress, which are all linked to the functions of leukocytes. While the CRP-associated DNAm may be cell-type specific, understanding the DNAm association with CRP in peripheral blood leukocytes of multi-ethnic populations can assist in unveiling the molecular mechanism of how the process of inflammation affects the risks of developing common disease through epigenetic modifications.

Highlights

  • Inflammation plays a key role in the development of atherosclerosis and cardiovascular diseases [1]

  • We investigated the epigenetic associations of C-reactive protein (CRP), an inflammatory biomarker of cardiovascular diseases (CVD), by measuring over 27,000 DNA methylation (DNAm) sites in peripheral blood leukocytes (PBLs) of 966 African Americans

  • Using a large sample of AAs, we identified widespread CRPassociated DNAm sites across all 22 autosomes

Read more

Summary

Introduction

Inflammation plays a key role in the development of atherosclerosis and cardiovascular diseases [1]. The molecular mechanism underlying atherosclerosis involves the interplay between the immune system and environmental risk factors such as diet, exercise, and smoking. Biomarkers of the immune system, including serum levels of several inflammatory markers, such as C-reactive protein (CRP), fibrinogen, and interleukin 6 are independently associated with cardiovascular diseases (CVD) after adjustment for other known risk factors [2]. Epigenetic modification, through DNA methylation (DNAm) and other molecular mechanisms, can regulate gene expression levels and is an important molecular mechanism underlying disease development. Epigenetic modifications in the immune cells can affect their functionality in inflammatory responses of the human body, which play a key role in developing chronic conditions such as CVD

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call